Mircera

NDC 59353-405 · Vifor (International) Inc.

Generic nameMethoxy polyethylene glycol-epoetin beta

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA

Strength200 ug/.3mL

Pharmacologic classErythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]

Marketing categoryBLA

Packages

59353-405-09 — 1 SYRINGE, GLASS in 1 CARTON (59353-405-09) / 1 mL in 1 SYRINGE, GLASS

Billed under HCPCS

J0887 — Injection, epoetin beta, 1 microgram, (for esrd on dialysis) Medicare Part B payment limit (ASP + 6%): $1.09

J0888 — Injection, epoetin beta, 1 microgram, (for non esrd use) Medicare Part B payment limit (ASP + 6%): $1.09

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

59353-400 — Methoxy polyethylene glycol-epoetin beta, 59353-401 — Methoxy polyethylene glycol-epoetin beta, 59353-402 — Methoxy polyethylene glycol-epoetin beta, 59353-403 — Methoxy polyethylene glycol-epoetin beta, 59353-404 — Methoxy polyethylene glycol-epoetin beta, 59353-406 — Methoxy polyethylene glycol-epoetin beta, 59353-407 — Methoxy polyethylene glycol-epoetin beta, 59353-408 — Methoxy polyethylene glycol-epoetin beta

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.